ClinicalTrials.gg
CompletedNCT02752581Updated Apr 27, 2016

Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee Surgery

An interventional study of Suction drain and No suction drain in Chondropathy, Knee Effusion and Knee Hemarthrosis, sponsored by Mert Özcan. Completed. Open to participants aged 16 Years to 70 Years. Per ClinicalTrials.gov, last updated 2016-04-27.

Sponsored by Mert Özcan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
16 Years to 70 Years
Sex
All
01

Study summary

The study was designed to investigate efficacy of suction drains in arthroscopic knee surgery, rather than anterior cruciate ligament (ACL) reconstruction. two groups were randomised, and suction drain was applied to one group, and the other group as the control group without a suction drain.

Read the detailed description

The groups were compared in terms of patellar shock, knee effusion, knee scoring systems, range of motion, loss of labour, hospitalization time. Also different arthroscopic procedures such as meniscectomy, meniscus repair, synovectomy and microfracture were evaluated in terms of need for a suction drain. The controls was at 1st and 15th day, 6th week and 3rd month.

02

Conditions studied

  • Chondropathy
  • Knee Effusion
  • Knee Hemarthrosis

Browse trials for

Keywords

  • suction drain
  • knee arthroscopy
  • knee pain
03

In context

Cartilage Diseases

38 studies on the registry are indexed under Cartilage Diseases; 3 are open to participants now.

This study's enrollment of 110 is close to the median of 100 across 24 interventional studies indexed under Cartilage Diseases.

Browse Cartilage Diseases studies →

Lead sponsor

This is the only study on the registry with Mert Özcan as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with knee derangement and accepted to enroll to the study

Exclusion criteria

Exclusion Criteria:

  • intraarticular fracture, ACL surgery, arthrotomy, bleeding disorder,
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
110 participants (actual)

Study arms

  • Other
    Drain Group

    Suction drain was applied to these patients after arthroscopic knee surgery.

    Device: Suction drain

  • Other
    Control Group

    No suction drain was applied to this group, therefore used as a control group.

    Device: No suction drain

Interventions

  • DeviceSuction drain

    A suction drain is used to remove excess fluid from tissues after surgery.

    Also known as: Hemovac drain

  • DeviceNo suction drain

    A suction drain is used to remove excess fluid from tissues after surgery.

06

What researchers measure

Primary outcomes

  1. Activity Pain

    Severity of pain was evaluated with Visual Analogue Scale (VAS). VAS is a horizontal line divided into ten equal intervals in which zero represents no pain and 10 represents the worst pain ever felt.

    Time frame: 3 months

  2. Rest Pain

    Severity of pain was evaluated with Visual Analogue Scale (VAS). VAS is a horizontal line divided into ten equal intervals in which zero represents no pain and 10 represents the worst pain ever felt.

    Time frame: 3 months

  3. Range of Motion

    Range of motion is measures in terms of angular degrees.

    Time frame: 3 months

Secondary outcomes

  1. Lysholm

    Lysholm is a scoring system from zero to one hundred. It measures subjective complaints of the patients.

    Time frame: 3 months

  2. International Knee Documentation Committee Score

    is a scoring system from zero to one hundred. It measures subjective complaints of the patients.

    Time frame: 3 months

  3. hospitalization time

    It is measured in days. It shows the period of hospitalization time, from surgery to discharge.

    Time frame: 1 month

  4. loss of labour time

    It is measured in days. It shows the time from discharge to beginning of work.

    Time frame: 1 month

Other outcomes

  1. Amount of drainage

    The amount of fluid in suction drain. It is measured with cubic centimetre (cc).

    Time frame: 1 day

  2. patellar shock

    Patellar shock was graded in four scales: Grade 1, some notable fluid, Grade 2, minimally elevated patella, Grade 3, patellar ballottement, and Grade 4, tense knee capsule, unable to compress patella.

    Time frame: 1.5 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Browett JP, Gibbs AN, Copeland SA, Deliss LJ. The use of suction drainage in the operation of meniscectomy. J Bone Joint Surg Br. 1978 Nov;60-B(4):516-9. doi: 10.1302/0301-620X.60B4.711799. PubMed 711799 ↗
  • Alkan K, Unay K, Berkem L, Guven M, Poyanli O. Suction drainage influence on knee effusion following partial meniscectomy with partial fat pad or synovium resection. Acta Orthop Traumatol Turc. 2011;45(4):221-4. doi: 10.3944/AOTT.2011.2545. PubMed 21908960 ↗
  • Tatari H, Dervisbey M, Muratli K, Ergor A. Report of experience in 190 patients with the use of closed suction drainage in arthroscopic knee procedures. Knee Surg Sports Traumatol Arthrosc. 2005 Sep;13(6):458-62. doi: 10.1007/s00167-004-0537-1. Epub 2004 Nov 13. PubMed 16170580 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2009, a primary completion of Dec 2012 and a completion of Apr 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 19, 2016
First posted
Apr 27, 2016
Start
Jan 2009
Primary completionActual
Dec 2012
CompletionActual
Apr 2013
Last update
Apr 27, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02752581
Lead sponsor
Mert Özcan
Responsible party
Mert Özcan (Assoc. Prof., Trakya University) — Sponsor-investigator
First posted
Apr 27, 2016
Start date
Jan 2009
Primary completion
Dec 2012
Completion
Apr 2013
Last update
Apr 27, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion